Business Description
TriSalus Life Sciences Inc
NAICS : 339112
SIC : 3845
ISIN : US89680M1018
Description
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines?Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.48 | |||||
| Equity-to-Asset | -0.74 | |||||
| Debt-to-Equity | -1.15 | |||||
| Debt-to-EBITDA | -0.45 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -16.72 | |||||
| Beneish M-Score | -3.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | 64.95 | |||||
| Future 3-5Y Total Revenue Growth Rate | 54.41 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.67 | |||||
| 9-Day RSI | 68.25 | |||||
| 14-Day RSI | 61.78 | |||||
| 6-1 Month Momentum % | -22.16 | |||||
| 12-1 Month Momentum % | -48.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | |||||
| Quick Ratio | 2 | |||||
| Cash Ratio | 1.14 | |||||
| Days Inventory | 305.74 | |||||
| Days Sales Outstanding | 55.65 | |||||
| Days Payable | 232.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -15.95 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.1 | |||||
| Operating Margin % | -158.12 | |||||
| Net Margin % | -205.51 | |||||
| FCF Margin % | -167.27 | |||||
| ROA % | -201.58 | |||||
| ROIC % | -462.45 | |||||
| ROC (Joel Greenblatt) % | -1427.41 | |||||
| ROCE % | -346.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.4 | |||||
| EV-to-EBIT | -2.59 | |||||
| EV-to-Forward-EBIT | -10.75 | |||||
| EV-to-EBITDA | -2.63 | |||||
| EV-to-Forward-EBITDA | -21.22 | |||||
| EV-to-Revenue | 5.14 | |||||
| EV-to-Forward-Revenue | 3.48 | |||||
| EV-to-FCF | -3.07 | |||||
| Earnings Yield (Greenblatt) % | -38.61 | |||||
| FCF Yield % | -31.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TLSI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TriSalus Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 26.891 | ||
| EPS (TTM) ($) | -2.49 | ||
| Beta | 0 | ||
| Volatility % | 123.04 | ||
| 14-Day RSI | 61.78 | ||
| 14-Day ATR ($) | 0.367442 | ||
| 20-Day SMA ($) | 4.1155 | ||
| 12-1 Month Momentum % | -48.23 | ||
| 52-Week Range ($) | 3.5 - 10.42 | ||
| Shares Outstanding (Mil) | 30.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TriSalus Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TriSalus Life Sciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
TriSalus Life Sciences Inc Frequently Asked Questions
What is TriSalus Life Sciences Inc(TLSI)'s stock price today?
The current price of TLSI is $4.75. The 52 week high of TLSI is $10.42 and 52 week low is $3.50.
When is next earnings date of TriSalus Life Sciences Inc(TLSI)?
The next earnings date of TriSalus Life Sciences Inc(TLSI) is 2025-04-01 Est..
Does TriSalus Life Sciences Inc(TLSI) pay dividends? If so, how much?
TriSalus Life Sciences Inc(TLSI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers